"levonorgestrel 52MG for contraception or treatment of abnormal uterine bleeding" (Master's). Candidate: Rebeca Mitestainer Furlani. Advisor: professor Ilza Maria Urbano Monteiro. May 6, 2021, at 9 am, entirely remotely.
Expulsion rates in users of the 52MG levonorgestrel-releasing intrauterine system for contraception or treatment of abnormal uterine bleeding
